Back to top
more

Boston Scientific (BSX)

(Delayed Data from NYSE)

$87.59 USD

87.59
5,119,705

-1.18 (-1.33%)

Updated Nov 14, 2024 04:00 PM ET

After-Market: $87.59 0.00 (0.00%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.10%
2Buy17.80%
3Hold9.50%
4Sell2.70%
5Strong Sell2.70%
S&P50011.20%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

C Value C Growth F Momentum C VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 34% (84 out of 250)

Industry: Medical - Products

Zacks News

Boston Scientific (BSX) Q2 Earnings and Revenues Beat Estimates

Boston Scientific (BSX) delivered earnings and revenue surprises of 20.59% and 1.02%, respectively, for the quarter ended June 2018. Do the numbers hold clues to what lies ahead for the stock?

    Boston Scientific (BSX) Beats on Q2 Earnings and Revenues

    Boston Scientific (BSX) has posted impressive results by delivering revenue growth across all segments in Q2.

      Medical Product Earnings Lineup for Jul 25: TMO, BSX & More

      The Medical product market further gains momentum on the back of a recent two-year suspension of the controversial 2.3% Medical Device tax.

        What's in the Cards for Zimmer Biomet (ZBH) in Q2 Earnings?

        Focusing on the thrust areas like quality correction, supply recovery efforts and product introductions, Zimmer Biomet (ZBH) is expected to retain robust top-line numbers within its S.E.T. arm.

          LZAGY vs. BSX: Which Stock Is the Better Value Option?

          LZAGY vs. BSX: Which Stock Is the Better Value Option?

            AngioDynamics (ANGO) Q4 Performance Dull, Competition Rife

            AngioDynamics' (ANGO) fourth-quarter performance dull; stiff competition a serious concern.

              Mark Vickery headshot

              Top Research Reports for AT&T, Home Depot & Cisco

              Today's Research Daily features new research reports on 16 major stocks, including AT&T (T), Home Depot (HD) and Cisco (CSCO).

                Thermo Fisher (TMO) to Report Q2 Earnings: What's in Store?

                Thermo Fisher (TMO) continues with its impressive performance momentum across analytical instrument businesses witnessing escalating global demand.

                  Can Strategic Alliances Aid LabCorp's (LH) Q2 Earnings?

                  LabCorp (LH) is expected to gain traction from a solid LabCorp Diagnostics segment in Q2, courtesy of a favorable price, mix, tuck-in acquisitions and organic volume.

                    Can Rhythm and Neuro Aid Boston Scientific (BSX) Q2 Earnings?

                    Boston Scientific (BSX) set to ride high on strength in Rhythm and Neuro business in Q2.

                      Boston Scientific (BSX) Q2 Earnings: Is a Beat in Store?

                      Boston Scientific (BSX) expects to consistently gain from impressive growth across all business lines and geographies.

                        Why You Should Add Boston Scientific (BSX) to Your Portfolio

                        Boston Scientific's (BSX) agreement for Cryterion Medical buyout in the field of atrial fibrillation buoys investor optimism on the stock.

                          Is Boston Scientific (BSX) Outperforming Other Medical Stocks This Year?

                          Is (BSX) Outperforming Other Medical Stocks This Year?

                            Will Core Segmental Growth Aid Stryker (SYK) in Q2 Earnings?

                            Stryker's (SYK) strong segmental performance and acquisition-driven strategy are likely to drive Q2 earnings.

                              Boston Scientific to Buy Cryterion Medical to Widen EP Suite

                              Boston Scientific (BSX) forges ahead with initiatives to strengthen its hold in the high-potential EP market.

                                Here's Why You Should Invest in Baxter (BAX) Stock Right Now

                                Baxter's (BAX) raised 2018 guidance and strong international presence make it a lucrative pick.

                                  Zacks.com featured highlights include: General Motors, Boston Scientific, T. Rowe Price, AMC Networks and Celanese

                                  Zacks.com featured highlights include: General Motors, Boston Scientific, T. Rowe Price, AMC Networks and Celanese

                                    Supriyo Bose headshot

                                    5 ROE Stocks to Buy as Proposed Auto Tariffs Rattle Markets

                                    ROE is often used to compare the profitability of a company with other firms in the industry - the higher, the better.

                                      Zacks.com featured highlights include: Anthem, Merit Medical, Boston Scientific, Grand Canyon and PetMed

                                      Zacks.com featured highlights include: Anthem, Merit Medical, Boston Scientific, Grand Canyon and PetMed

                                        7 GARP Stocks to Scoop Up for Maximum Returns

                                        Growth at a reasonable price or GARP strategy helps investors gain exposure to stocks that have impressive prospects and are trading at a discount.

                                          LZAGY vs. BSX: Which Stock Is the Better Value Option?

                                          LZAGY vs. BSX: Which Stock Is the Better Value Option?

                                            Will Walgreens (WBA) Q3 Earnings Gain From Overall Strength?

                                            Walgreens Boots' (WBA) sales rise at the Retail Pharmacy USA segment on account of tie-ups along with strength in other businesses buoys optimism.

                                              Has Boston Scientific (BSX) Outpaced Other Medical Stocks This Year?

                                              Is Boston Scientific Corporation (BSX) Outperforming Other Medical Stocks This Year?

                                                Sweta Jaiswal headshot

                                                Tap Cardiovascular Devices Market Boom With These 3 Stocks

                                                Consider these three stocks in the rapidly-growing cardiovascular devices market.

                                                  BSX or BAX: Which is a Better Pick for Your Portfolio Now?

                                                  After considering various parameters and fundamentals, we help you make a choice between Boston Scientific (BSX) and Baxter (BAX).